Recurrent infections with an AmpC-PE occurred more frequently among patients treated with carbapenems as compared to patients treated with cefepime; however, this did not reach statistical significance likely due to the low rate of recurrences in this study population.
← all excerpts
Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
1
—
—